Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (191-200 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Pharmacology|March 12, 1985
Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?W A Wolf, M B Youdim, D M Kuhn
Biochemical Society Transactions|January 1, 1975
Effect of age on the development and properties of brain monoamine oxidaseM B Youdim, D G Grahame-Smith, M Holzbauer
Metabolism: Clinical and Experimental|December 1, 1993
Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatilityZ Hochberg, M Phillip, M B Youdim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 1999
Apomorphine protects against MPTP-induced neurotoxicity in miceE Grünblatt, S Mandel, T Berkuzki, et al.
Journal of Neural Transmission. Supplementum|May 21, 1999
Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicityE Grünblatt, S Mandel, M Gassen, et al.
Journal of Neural Transmission|January 1, 1973
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the ratF Javoy, M B Youdim, Y Agid, et al.
Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.
Brain Research|April 21, 1987
Regulation of central and peripheral benzodiazepine receptors in progesterone-treated ratsM Gavish, A Weizman, M B Youdim, et al.
Annals of the New York Academy of Sciences|July 21, 2001
The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivoM B Youdim, A Wadia, W Tatton, et al.
Journal of Neurochemistry|October 1, 1986
Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the ratM Gavish, A Weizman, F Okun, et al.
Pageof 35

Showing results (191-200 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Pharmacology|March 12, 1985
Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?W A Wolf, M B Youdim, D M Kuhn
Biochemical Society Transactions|January 1, 1975
Effect of age on the development and properties of brain monoamine oxidaseM B Youdim, D G Grahame-Smith, M Holzbauer
Metabolism: Clinical and Experimental|December 1, 1993
Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatilityZ Hochberg, M Phillip, M B Youdim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 1999
Apomorphine protects against MPTP-induced neurotoxicity in miceE Grünblatt, S Mandel, T Berkuzki, et al.
Journal of Neural Transmission. Supplementum|May 21, 1999
Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicityE Grünblatt, S Mandel, M Gassen, et al.
Journal of Neural Transmission|January 1, 1973
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the ratF Javoy, M B Youdim, Y Agid, et al.
Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.
Brain Research|April 21, 1987
Regulation of central and peripheral benzodiazepine receptors in progesterone-treated ratsM Gavish, A Weizman, M B Youdim, et al.
Annals of the New York Academy of Sciences|July 21, 2001
The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivoM B Youdim, A Wadia, W Tatton, et al.
Journal of Neurochemistry|October 1, 1986
Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the ratM Gavish, A Weizman, F Okun, et al.
Pageof 35